Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): <scp>D</scp> ata from randomized controlled trialsMatteo Monami, Edoardo Mannucci, Besmir Nreu et al.|Diabetes Obesity and Metabolism|2017Cited by 226
Review of methods for detecting glycemic disordersMichael Bergman, Martin Buysschaert, Mariana P. Monteiro et al.|Diabetes Research and Clinical Practice|2020Cited by 193
C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transportCristina D’Alessandris, Giorgio Sesti|Diabetologia|2007Cited by 128
Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistanceFrancesco Andreozzi, Giorgio Sesti|Diabetologia|2011Cited by 80
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic EffectRosaria Vincenza Giglio, Manfredi Rizzo, Dragana Nikolić et al.|Metabolites|2020Cited by 51